scispace - formally typeset
Open AccessJournal Article

Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).

Reads0
Chats0
TLDR
Quantitative immunoblot analysis provides compelling evidence that A68 proteins are generated from tau-proteins in selected regions of the AD brain where neurofibrillary lesions comprised of paired helical filaments accumulate.
About
This article is published in Laboratory Investigation.The article was published on 1992-02-01 and is currently open access. It has received 120 citations till now. The article focuses on the topics: Neurofibrillary tangle & Senile plaques.

read more

Citations
More filters
Journal ArticleDOI

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

TL;DR: In this paper, the authors studied wild-type and P301S mutant human tau transgenic (Tg) mice and found that tangle formation was preceded by microglial activation.
Journal ArticleDOI

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

TL;DR: It is demonstrated that native A68 does not bind to microtubules (MTs), yet dephosphorylated A68 regains the ability to bind to MTs, and phosphorylation of Ser396 may destabilize MTs in AD, resulting in the degeneration of affected cells.
Journal ArticleDOI

Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding

TL;DR: Although MAP kinase efficiently phosphorylates many Ser/Thr-Pro motifs of tau, its effect on microtubule binding is only moderate, and phosphorylation of a single residue, Ser262, has a major effect on binding.
Journal ArticleDOI

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

TL;DR: Frontal sections of the temporal lobe of human adult brains are studied for cytoskeleton changes using immunostaining with the antibodies AT8 and Alz-50 and selective silver impregnation methods for neurofibrillary changes of the Alzheimer type to suggest changes which occur in the neuronal processes in the absence of alterations in their immediate surroundings.
Journal ArticleDOI

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

TL;DR: It is demonstrated that elevated tau/PHFtau levels are consistently found in CSF of AD patients and CSF-tau may therefore be useful as a positive biochemical marker, to discriminate AD from normal aging, PD, and depressive pseudodementia.
Related Papers (5)